Cargando…

Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes

BACKGROUND: Diabetes mellitus is a growing global health challenge and affects patients of all ages. Treatment aims to keep blood glucose levels close to normal and to prevent or delay complications. However, adherence to antidiabetic medicines is often unsatisfactory. PURPOSE: Here, we established...

Descripción completa

Detalles Bibliográficos
Autores principales: QiMuge, NaRen, Fang, Xu, Chang, Baocheng, Li, Dong Mei, Li, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932313/
https://www.ncbi.nlm.nih.gov/pubmed/35310157
http://dx.doi.org/10.7717/peerj.13102
_version_ 1784671427955261440
author QiMuge, NaRen
Fang, Xu
Chang, Baocheng
Li, Dong Mei
Li, Yuanyuan
author_facet QiMuge, NaRen
Fang, Xu
Chang, Baocheng
Li, Dong Mei
Li, Yuanyuan
author_sort QiMuge, NaRen
collection PubMed
description BACKGROUND: Diabetes mellitus is a growing global health challenge and affects patients of all ages. Treatment aims to keep blood glucose levels close to normal and to prevent or delay complications. However, adherence to antidiabetic medicines is often unsatisfactory. PURPOSE: Here, we established and internally validated a medication nonadherence risk nomogram for use in Chinese type 2 diabetes mellitus (T2DM) patients. METHODS: This cross-sectional study was carried out from July–December 2020 on randomly selected T2DM patients visiting a diabetes clinic and included 753 participants. Adherence was analyzed based on an eight-item Morisky Medication Adherence Scale (MMAS-8). Other data, including patient demographics, treatment, complications, and comorbidities, were also collected on questionnaires. Optimization of feature selection to develop the medication nonadherence risk model was achieved using the least absolute shrinkage and selection operator regression model (LASSO). A prediction model comprising features selected from LASSO model was designed by applying multivariable logistic regression analysis. The decision curve analysis, calibration plot, and C-index were utilized to assess the performance of the model in terms of discrimination, calibration, and clinical usefulness. Bootstrapping validation was applied for internal validation. RESULTS: The prediction nomogram comprised several factors including sex, marital status, education level, employment, distance, self-monitoringofbloodglucose, disease duration, and dosing frequency of daily hypoglycemics (pills, insulin, or glucagon-like peptide-1). The model exhibited good calibration and good discrimination (C-index = 0.79, 95% CI [0.75–0.83]). In the validation samples, a high C-index (0.75) was achieved. Results of the decision curve analysis revealed that the nonadherence nomogram could be applied in clinical practice in cases where the intervention is decided at a nonadherence possibility threshold of 12%. CONCLUSION: The number of patients who adhere to anti-diabetes therapy was small. Being single male, having no formal education, employed, far from hospital, long disease duration, and taking antidiabetics twice or thrice daily, had significant negative correlation with medication adherence. Thus, strategies for improving adherence are urgently needed.
format Online
Article
Text
id pubmed-8932313
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-89323132022-03-19 Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes QiMuge, NaRen Fang, Xu Chang, Baocheng Li, Dong Mei Li, Yuanyuan PeerJ Diabetes and Endocrinology BACKGROUND: Diabetes mellitus is a growing global health challenge and affects patients of all ages. Treatment aims to keep blood glucose levels close to normal and to prevent or delay complications. However, adherence to antidiabetic medicines is often unsatisfactory. PURPOSE: Here, we established and internally validated a medication nonadherence risk nomogram for use in Chinese type 2 diabetes mellitus (T2DM) patients. METHODS: This cross-sectional study was carried out from July–December 2020 on randomly selected T2DM patients visiting a diabetes clinic and included 753 participants. Adherence was analyzed based on an eight-item Morisky Medication Adherence Scale (MMAS-8). Other data, including patient demographics, treatment, complications, and comorbidities, were also collected on questionnaires. Optimization of feature selection to develop the medication nonadherence risk model was achieved using the least absolute shrinkage and selection operator regression model (LASSO). A prediction model comprising features selected from LASSO model was designed by applying multivariable logistic regression analysis. The decision curve analysis, calibration plot, and C-index were utilized to assess the performance of the model in terms of discrimination, calibration, and clinical usefulness. Bootstrapping validation was applied for internal validation. RESULTS: The prediction nomogram comprised several factors including sex, marital status, education level, employment, distance, self-monitoringofbloodglucose, disease duration, and dosing frequency of daily hypoglycemics (pills, insulin, or glucagon-like peptide-1). The model exhibited good calibration and good discrimination (C-index = 0.79, 95% CI [0.75–0.83]). In the validation samples, a high C-index (0.75) was achieved. Results of the decision curve analysis revealed that the nonadherence nomogram could be applied in clinical practice in cases where the intervention is decided at a nonadherence possibility threshold of 12%. CONCLUSION: The number of patients who adhere to anti-diabetes therapy was small. Being single male, having no formal education, employed, far from hospital, long disease duration, and taking antidiabetics twice or thrice daily, had significant negative correlation with medication adherence. Thus, strategies for improving adherence are urgently needed. PeerJ Inc. 2022-03-15 /pmc/articles/PMC8932313/ /pubmed/35310157 http://dx.doi.org/10.7717/peerj.13102 Text en © 2022 QiMuge et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Diabetes and Endocrinology
QiMuge, NaRen
Fang, Xu
Chang, Baocheng
Li, Dong Mei
Li, Yuanyuan
Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes
title Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes
title_full Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes
title_fullStr Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes
title_full_unstemmed Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes
title_short Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes
title_sort predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932313/
https://www.ncbi.nlm.nih.gov/pubmed/35310157
http://dx.doi.org/10.7717/peerj.13102
work_keys_str_mv AT qimugenaren predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes
AT fangxu predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes
AT changbaocheng predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes
AT lidongmei predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes
AT liyuanyuan predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes